https://www.selleckchem.com/pr....oducts/tinengotinib.
38weeks, p=0.034) and rate of preterm delivery was higher (38.9 vs. 14.3, P=0.24). Four cases had associated structural anomalies (2 in each group), and two had minor genetic aberrations (1 in each group). Growth restriction is prevalent in fetuses with IHUPSVS, suggesting that fetal growth should be monitored. In equal measure, in cases with growth restriction, especially without other apparent cause, an intrahepatic shunt should be looked for. Growth restriction is prevalent in fetuses with IHUPSVS, suggesting that fetal growth s
Like
Comment
Share
